These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34109316)

  • 21. A retained intron in the 3'-UTR of
    Sharangdhar T; Sugimoto Y; Heraud-Farlow J; Fernández-Moya SM; Ehses J; Ruiz de Los Mozos I; Ule J; Kiebler MA
    EMBO Rep; 2017 Oct; 18(10):1762-1774. PubMed ID: 28765142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1.
    Beaujois R; Ottoni E; Zhang X; Gagnon C; Hassine S; Mollet S; Viranaicken W; DesGroseillers L
    BMC Cell Biol; 2017 Jul; 18(1):25. PubMed ID: 28705199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered Glutamate Receptor Ionotropic Delta Subunit 2 Expression in Stau2-Deficient Cerebellar Purkinje Cells in the Adult Brain.
    Pernice HF; Schieweck R; Jafari M; Straub T; Bilban M; Kiebler MA; Popper B
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30979012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia.
    Meyer LM; Koschade SE; Vischedyk JB; Thoelken M; Gubas A; Wegner M; Basoglu M; Knapp S; Kaulich M; Eimer S; Shaid S; Brandts CH
    Autophagy; 2023 Nov; 19(11):2982-2996. PubMed ID: 37439113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
    Liu Q; Garcia M; Wang S; Chen CW
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML.
    Kurata M; Rathe SK; Bailey NJ; Aumann NK; Jones JM; Veldhuijzen GW; Moriarity BS; Largaespada DA
    Sci Rep; 2016 Nov; 6():36199. PubMed ID: 27808171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia.
    Rathe SK; Moriarity BS; Stoltenberg CB; Kurata M; Aumann NK; Rahrmann EP; Bailey NJ; Melrose EG; Beckmann DA; Liska CR; Largaespada DA
    Sci Rep; 2014 Aug; 4():6048. PubMed ID: 25116387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
    Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
    Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens.
    Su R; Qing Y; Chen J
    Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The brain-specific double-stranded RNA-binding protein Staufen2 is required for dendritic spine morphogenesis.
    Goetze B; Tuebing F; Xie Y; Dorostkar MM; Thomas S; Pehl U; Boehm S; Macchi P; Kiebler MA
    J Cell Biol; 2006 Jan; 172(2):221-31. PubMed ID: 16418534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA- binding protein Stau2 is important for spindle integrity and meiosis progression in mouse oocytes.
    Cao Y; Du J; Chen D; Wang Q; Zhang N; Liu X; Liu X; Weng J; Liang Y; Ma W
    Cell Cycle; 2016 Oct; 15(19):2608-2618. PubMed ID: 27433972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The brain-specific double-stranded RNA-binding protein Staufen2: nucleolar accumulation and isoform-specific exportin-5-dependent export.
    Macchi P; Brownawell AM; Grunewald B; DesGroseillers L; Macara IG; Kiebler MA
    J Biol Chem; 2004 Jul; 279(30):31440-4. PubMed ID: 15166236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.
    Prieto C; Nguyen DTT; Liu Z; Wheat J; Perez A; Gourkanti S; Chou T; Barin E; Velleca A; Rohwetter T; Chow A; Taggart J; Savino AM; Hoskova K; Dhodapkar M; Schurer A; Barlowe TS; Vu LP; Leslie C; Steidl U; Rabadan R; Kharas MG
    Nat Cancer; 2021 Jul; 2():741-757. PubMed ID: 34458856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staufen2 regulates neuronal target RNAs.
    Heraud-Farlow JE; Sharangdhar T; Li X; Pfeifer P; Tauber S; Orozco D; Hörmann A; Thomas S; Bakosova A; Farlow AR; Edbauer D; Lipshitz HD; Morris QD; Bilban M; Doyle M; Kiebler MA
    Cell Rep; 2013 Dec; 5(6):1511-8. PubMed ID: 24360961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia.
    Gilan O; Talarmain L; Bell CC; Neville D; Knezevic K; Ferguson DT; Boudes M; Chan YC; Davidovich C; Lam EYN; Dawson MA
    Nat Struct Mol Biol; 2023 Oct; 30(10):1592-1606. PubMed ID: 37679565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity.
    Park E; Gleghorn ML; Maquat LE
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):405-12. PubMed ID: 23263869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of CRISPR technology to high content screening in primary neurons.
    Callif BL; Maunze B; Krueger NL; Simpson MT; Blackmore MG
    Mol Cell Neurosci; 2017 Apr; 80():170-179. PubMed ID: 28110021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells.
    Lenoir WF; Morgado M; DeWeirdt PC; McLaughlin M; Griffith AL; Sangree AK; Feeley MN; Esmaeili Anvar N; Kim E; Bertolet LL; Colic M; Dede M; Doench JG; Hart T
    Nat Commun; 2021 Nov; 12(1):6506. PubMed ID: 34764293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid Leukemia.
    Rodems BJ; Sharma S; Baker CD; Kaszuba CM; Ito T; Liesveld JL; Calvi LM; Becker MW; Jordan CT; Ashton JM; Bajaj J
    bioRxiv; 2024 May; ():. PubMed ID: 38798540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
    Saha S; Murmu KC; Biswas M; Chakraborty S; Basu J; Madhulika S; Kolapalli SP; Chauhan S; Sengupta A; Prasad P
    Front Oncol; 2019; 9():692. PubMed ID: 31448224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.